You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0793 Efficacy of IXEKIZUMAB improving SF-36 scores in biologic dmard-naive patients with active psoriatic arthritis: results from a phase 3 study (SPIRIT-P1)

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Psoriatic arthritis
AB0793 Efficacy of IXEKIZUMAB improving SF-36 scores in biologic dmard-naive patients with active psoriatic arthritis: results from a phase 3 study (SPIRIT-P1)
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017501
Jul 2017600
Aug 20172000
Sep 20172800
Oct 20171803
Nov 20172802
Dec 20171400
Jan 20182405
Feb 2018900
Mar 20181000
Apr 20183200
May 20182001
Jun 20181000
Jul 2018800
Aug 2018400
Sep 2018602
Oct 2018401
Nov 2018808
Dec 2018805
Jan 20191104
Feb 2019202
Mar 2019406
Apr 2019303
May 2019102
Jun 2019503
Jul 2019205
Aug 2019106
Oct 2019404
Nov 2019202
Dec 2019402
Jan 2020403
Feb 2020204
Mar 2020203
Apr 2020202
May 2020002
Jun 20201200
Jul 20201201
Aug 2020204
Sep 2020802
Oct 2020200
Nov 2020401
Dec 20201204
Jan 2021702
Feb 2021203
Mar 2021203
Apr 2021203
May 2021005
Jun 2021001
Jul 2021006
Sep 2021006
Oct 20212013
Nov 2021509
Dec 2021401
Jan 20221001
Feb 20221000
Mar 20221001
Apr 2022201
May 20221009
Jun 20221603
Jul 20221001
Aug 20221002
Sep 2022205
Oct 2022805
Nov 2022405
Dec 2022401
Jan 2023203
Feb 20231602
Mar 2023801
May 2023002
Jun 2023001
Jul 2023203
Aug 2023200
Sep 2023601
Oct 2023101
Nov 2023001
Dec 20231200
Jan 2024600
Feb 2024202
Mar 20243026
Total5430222